Private Wealth Asset Management’s Puma Biotechnology PBYI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-3,500
Closed -$28.4K – 972
2026
Q2
$28.4K Hold
3,500
– – ﹤0.01% 508
2026
Q1
$22.4K Hold
3,500
– – ﹤0.01% 545
2025
Q4
$20.8K Hold
3,500
– – ﹤0.01% 547
2025
Q3
$18.6K Hold
3,500
– – ﹤0.01% 538
2025
Q2
$12K Buy
3,500
+1,500
+75% +$4.79K ﹤0.01% 630
2025
Q1
$5.92K Buy
+2,000
New +$6.26K ﹤0.01% 714

Other funds holding PBYI

Private Wealth Asset Management's PBYI Position: Q3 2026 in Review

Private Wealth Asset Management sold out of Puma Biotechnology (PBYI) in Q3 2026, closing a stake of 3,500 shares — an estimated $28.4K sold.

Private Wealth Asset Management first reported a position in PBYI in Q1 2025 and held it in 6 quarters. The position peaked at $28.4K in Q2 2026. 156 funds tracked by Wall St. Rank hold PBYI as of Q3 2026.

  • Private Wealth Asset Management reported no remaining Puma Biotechnology position as of Q3 2026 after selling out during the quarter.
  • Private Wealth Asset Management sold 3,500 Puma Biotechnology shares in Q3 2026, an estimated $28.4K.
  • Private Wealth Asset Management first reported a position in Puma Biotechnology in Q1 2025 and held it in 6 quarters.
  • Private Wealth Asset Management's Puma Biotechnology position peaked at $28.4K in Q2 2026.
  • 156 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2026.

Based on Private Wealth Asset Management's 13F filing for Q3 2026, filed 10 Nov 2026.